Confirmation there is no prospect Australia can manufacture from scratch and under license one of the mRNA or adenovirus viral vector COVID-19 vaccines currently in development as South Korea becomes the latest country to secure supply of one of the leading candidates.
The local option is 'recombinant' or 'downstream' production
July 28, 2020 Latest NewsNews of the Day
Latest Video
New Stories
-
Arrotex Pharmaceuticals appoints experienced industry executive as CMO
August 4, 2026 - - Latest News -
The risk to patients is that new pricing policies could swamp any benefit from the HTA Review
August 4, 2026 - - Latest News -
Potential merger could create a new global oncology powerhouse
August 3, 2026 - - Latest News -
The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants
August 3, 2026 - - Latest News -
First new brain cancer treatment listed on PBS after more than 20 years
August 3, 2026 - - Latest News -
Funding for new chemotherapy-free immunotherapy combination for follicular lymphoma
August 3, 2026 - - Latest News -
Listing offers treatment option for Australians with tumour induced osteomalacia
August 3, 2026 - - Latest News

